Singular Genomics Systems... (OMIC)
NASDAQ: OMIC
· Real-Time Price · USD
20.01
0.00 (0.00%)
At close: Feb 20, 2025, 3:55 PM
Singular Genomics Systems Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.67M | 2.72M | 2.49M | 2.91M | 2.6M | 2.13M | 1.63M | 765K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.74M | 5.56M | 5.25M | 3.47M | 2.72M | 3.86M | 4.8M | 4.46M | 4.03M | 2.67M | 1.38M | 1.13M | 769K | 466K | 211K |
Gross Profit | -3.08M | -2.84M | -2.75M | -558K | -125K | -1.73M | -3.18M | -3.69M | -4.03M | -2.67M | -1.38M | -1.13M | -769K | -466K | -211K |
Operating Income | -93M | -99.47M | -104.27M | -102.8M | -100.05M | -100.2M | -96.84M | -93.49M | -90.63M | -83.4M | -73.04M | -61.28M | -49.19M | -39.51M | -32.39M |
Interest Income | 7.83M | 8.73M | 9.19M | 9.08M | 8.44M | 7.09M | 5.22M | 3.37M | 1.8M | 773K | 758K | 733K | 689K | 681K | 424K |
Pretax Income | -86.32M | -91.89M | -96.21M | -94.82M | -92.67M | -94.1M | -92.51M | -90.88M | -89.54M | -83.36M | -96.86M | -98.77M | -86.92M | -77.25M | -46.61M |
Net Income | -86.32M | -91.89M | -96.21M | -93.33M | -89.76M | -90.28M | -88.43M | -88.27M | -88.36M | -83.08M | -96.84M | -98.77M | -86.92M | -77.25M | -46.61M |
Selling & General & Admin | 46.45M | 51.5M | 54.49M | 54.48M | 53.09M | 51.8M | 49.09M | 47.27M | 45.74M | 42.33M | 36.34M | 28.62M | 20.18M | 13.32M | 8.56M |
Research & Development | 43.48M | 45.13M | 47.03M | 47.76M | 46.83M | 48.35M | 47.78M | 46.2M | 44.89M | 41.07M | 36.69M | 32.66M | 29.02M | 26.19M | 23.83M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | -6K | -23.8M | -35.2M | -35.21M | -35.18M | -11.38M |
Operating Expenses | 89.93M | 96.63M | 101.52M | 102.24M | 99.92M | 100.14M | 96.88M | 93.46M | 90.63M | 83.4M | 73.04M | 61.28M | 49.19M | 39.51M | 32.39M |
Interest Expense | 1.14M | 1.14M | 1.13M | 1.1M | 1.06M | 983K | 880K | 763K | 712K | 735K | 800K | 846K | 869K | 837K | 840K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -11.81M | -11.81M | -11.81M | -11.81M | -8.19M | -8.19M | -8.19M | -8.19M | n/a | n/a | n/a |
Cost & Expenses | 95.67M | 102.19M | 106.76M | 105.71M | 102.64M | 102.34M | 98.47M | 94.25M | 90.63M | 83.4M | 73.04M | 61.28M | 49.19M | 39.51M | 32.39M |
Income Tax Expense | n/a | n/a | n/a | -1.49M | -2.92M | -3.82M | -4.08M | -2.61M | -1.54M | -489K | -228K | -214K | 150K | n/a | n/a |
Shares Outstanding (Basic) | 2.5M | 2.48M | 2.47M | 2.45M | 2.44M | 2.42M | 2.4M | 2.39M | 2.37M | 2.36M | 2.37M | 2.41M | 2.39M | 2.33M | 2.27M |
Shares Outstanding (Diluted) | 2.5M | 2.48M | 2.47M | 2.45M | 2.44M | 2.42M | 2.4M | 2.39M | 2.37M | 2.36M | 2.37M | 2.41M | 2.39M | 2.33M | 2.27M |
EPS (Basic) | -34.92 | -37.37 | -39.38 | -38.47 | -37.23 | -37.7 | -37.17 | -37.22 | -37.19 | -34.92 | -40.96 | -42.22 | -37.43 | -33.49 | -20.36 |
EPS (Diluted) | -34.92 | -37.37 | -39.38 | -38.47 | -37.23 | -37.7 | -37.17 | -37.22 | -37.19 | -34.92 | -40.96 | -42.22 | -37.43 | -33.49 | -20.36 |
EBITDA | -78.33M | -83.72M | -87.96M | -86.5M | -84.33M | -86.03M | -84.88M | -84.72M | -84.79M | -79.95M | -94.67M | -96.79M | -85.09M | -75.57M | -45.05M |
EBIT | -85.18M | -90.75M | -95.08M | -93.72M | -91.61M | -93.12M | -91.63M | -90.12M | -88.83M | -82.62M | -96.06M | -97.92M | -86.05M | -76.41M | -45.77M |
Depreciation & Amortization | 6.85M | 7.03M | 7.13M | 7.22M | 7.29M | 7.09M | 6.75M | 5.39M | 4.03M | 2.67M | 1.38M | 1.13M | 967K | 835K | 719K |